Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeVascular Robotics

Vascular Robotics

Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers

Mark J. Toland, President and Chief Executive Officer of Corindus. “We believe the transaction will deliver immediate, compelling and certain value to all Corindus stockholders, as well as substantial benefits to our customers.

CorPath® GRX Systems Installed at HCA Healthcare Facilities

The new systems are now installed in hospital locations in Florida and Texas, bringing the total number of HCA hospitals utilizing CorPath GRX to three.

Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System

2/14/19: An expansion of CorPath GRX Vascular Robotic System to treat neurovascular conditions would represent a major stepping stone towards our goal of revolutionizing stroke treatment,” said Mark Toland, President and Chief Executive Officer of Corindus.

Corindus to Feature Recent Advancements in Robotic Technology at SCAI 2018 Scientific Sessions

4/23/18: Optimizing care with CorPath GRX: Hot topics in robotic interventions.

Corindus Receives FDA Clearance for First Automated Robotic Movement in technIQ™ Series for CorPath GRX Platform

3/5/18: -Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the first automated robotic movement designed for the CorPath GRX platform.

Corindus Receives FDA Clearance for CorPath® GRX System in Peripheral Vascular Interventions

2/20/18: Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration for use of its CorPath GRX System in peripheral vascular interventions. The CorPath System is the first and only FDA-cleared medical device to bring robotic precision to both percutaneous coronary intervention and peripheral vascular intervention procedures.

Corindus Partners with Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians

12/1/17: Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Houston Methodist DeBakey Heart & Vascular Center, a leading cardiovascular center located in the Texas Medical Center, has launched the first vascular robotic program in the Houston area with the installation of two CorPath GRX Systems.

Corindus to Feature CorPath® GRX System at the Transcatheter Cardiovascular Therapeutics 2017 Conference

Corindus Vascular Robotics, Inc. (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it will be participating in the Transcatheter Cardiovascular Therapeutics (TCT) 2017 Conference to be held October 29 – November 2 in Denver, CO. Robotic-assisted percutaneous coronary intervention (PCI) will be featured throughout the conference, including in the exhibit hall, presentations, and during a breakfast symposium.

Corindus Announces Opening of First International Robotic Training Center

Corindus Vascular Robotics, Inc. announced today the opening of the first international CorPath GRX Robotic Center in Tokyo, Japan. Earlier this year, Corindus partnered with Japan Medicalnext Co., Ltd., a wholly-owned entity of MC Healthcare, Inc. (subsidiary...

Corindus Announces First Patient Enrolled in PRECISION GRX Registry

Corindus Vascular Robotics, Inc. , a leading developer of precision vascular robotics, today announced first patient enrollment in the PRECISION GRX Registry, a post-market study to continue market surveillance of the Company's second generation CorPath GRX System. Corindus...

Corindus to Feature CorPath® GRX System at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions

Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) announced today that it will be participating in the SCAI 2017 Scientific Sessions to be held May 10-13 in New Orleans, LA. Robotic-assisted percutaneous coronary intervention (PCI) will be featured...

By using this website you agree to accept Medical Device News Magazine Privacy Policy